- Home
- VANI vs INCR Comparison
VANI vs INCR Comparison
Compare VANI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- INCR
- Stock Information
- Founded
- VANI 1998
- INCR 1994
- Country
- VANI United States
- INCR Israel
- Employees
- VANI 36
- INCR N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- VANI Health Care
- INCR Health Care
- Exchange
- VANI Nasdaq
- INCR Nasdaq
- Market Cap
- VANI 75.2M
- INCR 84.5M
- IPO Year
- VANI 2014
- INCR N/A
- Fundamental
- Price
- VANI $1.40
- INCR $1.55
- Analyst Decision
- VANI Strong Buy
- INCR
- Analyst Count
- VANI 1
- INCR 0
- Target Price
- VANI $4.00
- INCR N/A
- AVG Volume (30 Days)
- VANI 134.3K
- INCR 24.4K
- Earning Date
- VANI 08-12-2025
- INCR 08-15-2025
- Dividend Yield
- VANI N/A
- INCR N/A
- EPS Growth
- VANI N/A
- INCR N/A
- EPS
- VANI N/A
- INCR N/A
- Revenue
- VANI N/A
- INCR $65,575,323.00
- Revenue This Year
- VANI N/A
- INCR $69.54
- Revenue Next Year
- VANI N/A
- INCR $41.75
- P/E Ratio
- VANI N/A
- INCR N/A
- Revenue Growth
- VANI N/A
- INCR N/A
- 52 Week Low
- VANI $0.91
- INCR $1.17
- 52 Week High
- VANI $1.50
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- VANI 74.26
- INCR 60.11
- Support Level
- VANI $1.26
- INCR $1.48
- Resistance Level
- VANI $1.30
- INCR $1.56
- Average True Range (ATR)
- VANI 0.06
- INCR 0.06
- MACD
- VANI 0.00
- INCR 0.01
- Stochastic Oscillator
- VANI 69.70
- INCR 80.99
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.